Skip to content
Company
About AGP
Vision & Mission
Detail of Associated Concerns
Leadership Team
History Timeline
Governance
Auditors, Advisors ,Share Registrar and Bankers
Election of Directors
Board and its Committees
Share Holding Pattern
Key Elements of Significant Policies
Investor Relations
Investor Information
Financial Statements
Code of Conduct
Financial Highlights
Latest EPS, P/E Ratio, and Break-up value of share
Free Float
List of Unpaid/Unclaimed Shares & Dividend
Name & Address of share registrar
PSX symbol and link, Rating
Investor Contacts
Notices & Forms
Corporate Social Responsibility
Corporate Briefing Session
Media
Certifications & Awards
Documentary
Events Gallery
Announcements/Clarifications
Website Compliance Certificate
Business Partners
Distribution Channel
Export
Partnerships
Products
Product List
Product Quality Management
Product Safety
Careers
Why AGP
Job Openings
English
اردو
Home
>
Generics
>
Daclatasvir
Daclatasvir
MyDekla
MyDekla use in combination with other medicinal products for the treatment of chronic hepatitis C virus (HCV) infection in adults
